SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
CLPT

ClearPoint Neuro, Inc. (NASDAQ:CLPT)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$6.91-$0.40 (-5.47%)
 
Market cap
$221M
Insider Score
Health Score
Analyst consensus
Listed since
May 22, 2012
Market Cap$221.49M-50.0%
Revenue (ttm)$45.49M+32.5%
Net Income-$36.13M-56.2%
EPS-$1.21-44.0%
Shares Out32.05M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,108,673
Open$7.15
Previous Close$7.31
Day's Range$6.85 - $7.45
52-Week Range$6.85 - $19.63
Beta1.36
AnalystsBuy
Price Target$21.50(+211.14%)
Earnings DateMar 16, 2027

About CLPT

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.

Address
120 S. Sierra Avenue, Solana Beach, CA, 92075, US
Market Cap
221 million
Employees
172
Industrial Classification
Medical - Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Selling
Sold
$1.80M
Bought
$0

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Moderate Buy
1 Buy0 Hold0 SellAvg target $18.00 (+160.5%)

1 firm rating CLPT in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Weak
From CLPT’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-5.47%
5 Days
-16.95%
1 Month
-25.30%
6 Months
-40.94%
1 Year
-50.00%

$CLPT stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in CLPT holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by CLPT's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

CLPT Estimated quarterly lobbying spending

Source: U.S. Senate LDA

CLPT Revenue by Segment

$17.99MTotal
Neurosurgery navigation and therapy$5.44M30.23%
Neurosurgery Navigation and Therapy - Disposable Products$5.44M30.23%
Biologics and drug delivery$4.89M27.21%
Capital equipment and software$1.74M9.68%
Capital Equipment and Software - Services$474.00K2.64%

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New CLPT patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to CLPT from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in CLPT

VTIVanguard Morningstar Total Stock Market ETF$7.18M
IWMiShares Russell 2000 ETF$5.29M
VXFVanguard Extended Market ETF$3.77M
IWOiShares Russell 2000 Growth ETF$1.96M
VTWOVanguard Russell 2000 ETF$1.77M
KOMPState Street SPDR S&P Kensho New Economies Composite ETF$918.76K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from CLPT’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
0
Analyst Ratings
40% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
6
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

FDHTFIDELITY DIGITAL HEALTH ETF1.26%
XHEState Street SPDR S&P Health Care Equipment ETF0.61%
IBRNiShares Neuroscience and Healthcare ETF0.37%
QQQSInvesco NASDAQ Future Gen 200 ETF0.34%
IWCiShares Micro-Cap ETF0.06%
KOMPState Street SPDR S&P Kensho New Economies Composite ETF0.05%
TMFXMotley Fool Next Index ETF0.01%

Weight is the stock’s share of each fund’s holdings.